Literature DB >> 11874827

Newly diagnosed rheumatoid arthritis.

M H Weisman1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11874827      PMCID： PMC1754068          DOI： 10.1136/ard.61.4.287

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  20 in total

Review 1.  When does rheumatoid arthritis begin and why do we need to know?

Authors:  J M Kim; M H Weisman
Journal:  Arthritis Rheum       Date:  2000-03

2.  Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group.

Authors:  P E Lipsky; D M van der Heijde; E W St Clair; D E Furst; F C Breedveld; J R Kalden; J S Smolen; M Weisman; P Emery; M Feldmann; G R Harriman; R N Maini
Journal:  N Engl J Med       Date:  2000-11-30       Impact factor: 91.245

Review 3.  Clinical guidelines: developing guidelines.

Authors:  P G Shekelle; S H Woolf; M Eccles; J Grimshaw
Journal:  BMJ       Date:  1999-02-27

4.  Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis.

Authors:  M Boers; A C Verhoeven; H M Markusse; M A van de Laar; R Westhovens; J C van Denderen; D van Zeben; B A Dijkmans; A J Peeters; P Jacobs; H R van den Brink; H J Schouten; D M van der Heijde; A Boonen; S van der Linden
Journal:  Lancet       Date:  1997-08-02       Impact factor: 79.321

5.  The clinical features of rheumatoid arthritis. Prognostic indices.

Authors:  C RAGAN
Journal:  JAMA       Date:  1962-08-25       Impact factor: 56.272

6.  The effect of glucocorticoids on joint destruction in rheumatoid arthritis. The Arthritis and Rheumatism Council Low-Dose Glucocorticoid Study Group.

Authors:  J R Kirwan
Journal:  N Engl J Med       Date:  1995-07-20       Impact factor: 91.245

7.  A reappraisal of HAQ disability in rheumatoid arthritis.

Authors:  F Wolfe
Journal:  Arthritis Rheum       Date:  2000-12

Review 8.  The links between joint damage and disability in rheumatoid arthritis.

Authors:  D L Scott; K Pugner; K Kaarela; D V Doyle; A Woolf; J Holmes; K Hieke
Journal:  Rheumatology (Oxford)       Date:  2000-02       Impact factor: 7.580

9.  No increased mortality in patients with rheumatoid arthritis: up to 10 years of follow up from disease onset.

Authors:  E J Kroot; M A van Leeuwen; M H van Rijswijk; M L Prevoo; M A Van 't Hof; L B van De Putte; P L van Riel
Journal:  Ann Rheum Dis       Date:  2000-12       Impact factor: 19.103

10.  The course of radiologic damage during the first six years of rheumatoid arthritis.

Authors:  H M Hulsmans; J W Jacobs; D M van der Heijde; G A van Albada-Kuipers; Y Schenk; J W Bijlsma
Journal:  Arthritis Rheum       Date:  2000-09
View more
  1 in total

Review 1.  Mitogen-activated protein kinases as therapeutic targets for rheumatoid arthritis.

Authors:  Verica Paunovic; Margaret M Harnett
Journal:  Drugs       Date:  2013-02       Impact factor: 9.546
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.